The majority of patients were admitted within 12 h of symptom onset, with 77.8% in the group without hs-cTnI elevation presenting with minor-to-moderate stroke (NIHSS 1–15) compared with 61% in the group with hs-cTnI elevation. Here, TNNI3 is linked to Stroke.